Vanda Pharmaceuticals Inc. (VNDA)

Vanda (VNDA) Stock Price & Analysis


VNDA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$5.75 - $11.90
Previous Close$6.11
Average Volume (3M)587.99K
Market Cap
Enterprise Value$152.52M
Total Cash (Recent Filing)$354.17M
Total Debt (Recent Filing)$155.71M
Price to Earnings (P/E)21.9
Aug 02, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.28
Shares Outstanding57,444,139
10 Day Avg. Volume493,612
30 Day Avg. Volume587,988
Standard Deviation0.14
Financial Highlights & Ratios
Price to Book (P/B)0.71
Price to Sales (P/S)5.62
Price to Cash Flow (P/CF)2.80
P/FCF Ratio2.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.59
Enterprise Value/Gross Profit0.60
Enterprise Value/Ebitda10.40
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Vanda Pharmaceuticals Inc.’s price range in the past 12 months?
Vanda Pharmaceuticals Inc. lowest stock price was $5.75 and its highest was $11.90 in the past 12 months.
    What is Vanda Pharmaceuticals Inc.’s market cap?
    Currently, no data Available
    When is Vanda Pharmaceuticals Inc.’s upcoming earnings report date?
    Vanda Pharmaceuticals Inc.’s upcoming earnings report date is Aug 02, 2023 which is in 66 days.
      How were Vanda Pharmaceuticals Inc.’s earnings last quarter?
      Vanda Pharmaceuticals Inc. released its earnings results on May 03, 2023. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of N/A by $0.06.
        Is Vanda Pharmaceuticals Inc. overvalued?
        According to Wall Street analysts Vanda Pharmaceuticals Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Vanda Pharmaceuticals Inc. pay dividends?
          Vanda Pharmaceuticals Inc. does not currently pay dividends.
          What is Vanda Pharmaceuticals Inc.’s EPS estimate?
          Vanda Pharmaceuticals Inc.’s EPS estimate is -$0.13.
            How many shares outstanding does Vanda Pharmaceuticals Inc. have?
            Vanda Pharmaceuticals Inc. has 57,444,138 shares outstanding.
              What happened to Vanda Pharmaceuticals Inc.’s price movement after its last earnings report?
              Vanda Pharmaceuticals Inc. reported an EPS of $0.06 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 7.512%.
                Which hedge fund is a major shareholder of Vanda Pharmaceuticals Inc.?
                Among the largest hedge funds holding Vanda Pharmaceuticals Inc.’s share is Hotchkis & Wiley Capital Management LLC. It holds Vanda Pharmaceuticals Inc.’s shares valued at 7M.


                  Vanda Stock Smart Score

                  The Vanda stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Vanda Pharmaceuticals Inc.

                  Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.


                  Top 5 ETFs holding VNDA

                  Market Value
                  Smart Score
                  Vanguard Health Care ETF
                  Fidelity MSCI Health Care Index ETF
                  iShares NASDAQ US Biotechnology UCITS ETF
                  Up to five ETFs with an Outperform Smart Score that hold VNDA. The ETFs are listed according to market value of VNDA within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Bluebird Bio
                  Avidity Biosciences
                  Century Therapeutics
                  HilleVax, Inc

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis